-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
-
Summary
-
PharmaCyte Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Investing Activities history and growth rate from Q2 2010 to Q2 2024.
- PharmaCyte Biotech, Inc. Net Cash Provided by (Used in) Investing Activities for the quarter ending July 31, 2024 was -$7M.
- PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2023 was -$5M.
- PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2022 was $0.000.
- PharmaCyte Biotech, Inc. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $0.000.
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Growth (%)